The ENGOT-cx11/GOG-3047/KEYNOTE-A18 randomized controlled trial demonstrated an overall survival benefit in cervical cancer patients treated with pembrolizumab during and after chemoradiotherapy as c…
Marginal Zone Lymphoma experts discussed recent advancements in all areas of MZL, while calling attention to gaps in knowledge in the 2024 MZL Scientific Workshop.
Journal of Neuro-Oncology – To evaluate the efficacy and safety of aumolertinib in treating non-small cell lung cancer (NSCLC) patients with leptomeningeal metastasis (LM) and…
A resubmitted biologics license application for linvoseltamab in relapsed/refractory multiple myeloma is under review by the FDA.
In the first episode in our series of WomenTalk on gynecologic oncology, we’ll learn all about cervical, endometrial and ovarian cancers.
Hisato Kawakami, MD, PhD, Tohoku University, Sendai, Japan, discusses balancing efficacy and safety with the use of trastuzumab deruxtecan in patients with HER2+ gastric cancer,…
Honor Someone you love! Support Stand Up To Cancer this Valentine’s Day and #KissCancerGoodbye
Financial toxicity is ubiquitous in cancer patients, including in patients enrolled in early phase clinical trials. The prevalence of financial toxicity has implications for policymakers.
A novel drug regimen tested for the first time by researchers at Fred Hutch Cancer Center has shown great promise in preventing moderate to severe…
The Trump Administration’s censorship extends beyond federal websites and datasets to include research to be published in academic journals.
